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Abstract. We developed a novel Plasmodium falciparum genotyping strategy based on the heteroduplex tracking
assay (HTA) method commonly used to genotype viruses. Because it can detect both sequence and size polymorphisms,
we hypothesized that HTA is more sensitive than current methods. To test this hypothesis, we compared the ability of
HTA and a nested polymerase chain reaction (PCR) to detect genetic diversity in 17 Thai samples. The HTA detected
more MSP1 sequence variants in eight isolates (47%), less sequence variants in three isolates (18%), and an equal
number of sequence variants in six isolates (35%), suggesting that HTA is equal to or more sensitive than the nested
PCR. This study is a proof of concept that HTA is a sensitive allelic discrimination method able to determine genetic
diversity in P. falciparum and warrants its use in studies of antimalarial drug efficacy.
INTRODUCTION
Plasmodium falciparum, the most virulent of the four para-
site species causing human malaria, exhibits significant ge-
netic diversity. This diversity is particularly striking in targets
of host immunity such as merozoite surface protein 1
(PfMSP1), which encodes a 190-kD membrane-anchored
protein that displays both size and nucleotide polymor-
phisms.1–4 Due to its high sequence divergence, the block 2
region of PfMSP1 is an ideal locus to delineate multiplicity of
infection. Several polymerase chain reaction (PCR) methods
have already been developed that exploit PfMSP1 diversity,
including the following: nested PCR, single-strand conforma-
tion polymorphism (SSCP), restriction fragment length poly-
morphism (RFLP), and direct DNA sequencing (reviewed by
Snounou and Beck5). Of these methods, the nested PCR is
used most often, and although very sensitive in its ability to
detect size polymorphisms, it has three main shortcomings: an
inability to detect DNA sequence polymorphisms, a dimin-
ished sensitivity at low parasite densities, and poor resolution
at high parasitemias.6
Capable of resolving multiple nucleotide sequences in a
single sample, the heteroduplex tracking assay (HTA) has
been used extensively to genotype human immunodeficiency
virus (HIV) and other viruses.7–9 When the HTA is used, a
radiolabeled DNA probe is annealed to a PCR-amplified
polymorphic sequence, and double-strand DNA duplexes are
formed with the complementary sequence. Perfect comple-
ments, termed homoduplexes, migrate according to size on a
native polyacrylamide gel, while partial DNA duplexes, such
as those caused by clustered base pair mismatches and/or size
polymorphisms, migrate more slowly. Because the assay is
sensitive to the conformation of the DNA, which is deter-
mined by the genotype, each HTA band represents a distinct
genetic variant and the overall banding pattern is a fingerprint
of the infection.
In this report, we describe a novel PfMSP1 HTA able to
discern genetically distinct sequence variants of P. falciparum.
The ability of this assay to distinguish basepair substitutions
as well as size polymorphisms introduces a novel, sequence-
sensitive technique that will augment our ability to distinguish
P. falciparum recrudescence from reinfection.
MATERIALS AND METHODS
Study samples. Informed consent, as approved by the ethics
committees of the University of North Carolina, the Thai
Ministry of Public Health, or the Malawi College of Medicine/
Ministry of Health, was obtained from all participants in this
research. The AF patient samples are from a cross-sectional
study in southeast Asia reported by Pickard and others.10 The
GR samples originated from a study in Tak Province on the
western border of Thailand; this region is considered an area
of low malaria transmission, with an estimated entomologic
inoculation rate of 1–2 infective bites per person per year
(Miller RS, unpublished data). In the GR study, patients with
P. falciparum malaria were treated with mefloquine, and
those found with recurrent P. falciparum infections within 42
days of enrollment were re-treated. Paired admission and re-
current infection samples were obtained and the parasitemia
per microliter was quantitated by light microscopy of Geimsa-
stained thick blood smears. Genomic DNA from these
samples was extracted as previously described.10 The
MHP1452 probe is from a malaria-positive, pregnant woman
in the Malaria and HIV in Pregnancy study reported by Mwa-
pasa and others.11
Amplification of the PfMSP1 block 2 by PCR. Amplifica-
tion of P. falciparum DNA was performed with a Peltier ther-
mal cycler (MJ Research, Waltham, MA) in a final volume of
50 L. Reactions consisted of 2 L of parasite DNA in 1×
PCR buffer, 1.5 mM MgCl2, 125 M of each dNTP, 1 unit of
HotStarTaq DNA polymerase (Qiagen, Valencia, CA), and
250 nM of forward and reverse primers (modified from
Kimura and others12; C1F: 5-GAAGATGCAGTATTGA-
CAGG-3, and C3R: 5-TGATTGGTTAAATCAAAGAG-
3). The amplification program consisted of preheating to
95°C for 15 minutes, followed by 24 cycles at 94°C for 1
minute, 50°C for 2 minutes, and 72°C for 2 minutes. The PCR
products were subjected to electrophoresis on 1.2% agarose
gels, visualized under ultraviolet light after staining with*These authors contributed equally to this article.
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ethidium bromide, and sized against a 100-basepair molecular
weight marker (Promega, Madison, WI). Successful amplifi-
cation resulted in products of approximately 300 basepairs.
All PCRs were done in duplicate to ensure reproducible sam-
pling of the sequence variants.
Plasmids and probes. The HTA probes were constructed
by amplifying block 2 of PfMSP1 from three Thai samples
(AF22, AF42, and AF63), and one African sample
(MHP1452). The PCR products were blunt-end cloned into
the pT7Blue vector using the Perfectly Blunt cloning kit
(Novagen, Inc., Madison, WI). Plasmid DNA was amplified
according to the manufacturer’s instructions and purified with
the Wizard Plus SV miniprep DNA Purification System
(Promega).
Ten micrograms of the PfMSP1 block 2-pT7Blue construct
was digested with Bam HI at 37°C for one hour and then end
labeled in the same buffer by filling in the Bam HI overhang
for 15 minutes at 25°C using 1× Eco pol buffer (New England
Biolabs, Beverly, MA), 10 mM dithiothreitol, 50 M dGTP,
50 Ci (-35S) of dATP (1,250 Ci/mmol; ICN, Irvine, CA),
and 10 units of Klenow fragment. The reaction was stopped
by the addition of EDTA (10 mM final concentration) and
heat inactivation at 75°C for 15 minutes. The radiolabeled
probe was released from the vector by digestion with Pst I at
37°C for one hour, and the probe was separated from the
vector after electrophoresis on an agarose gel. The radiola-
beled insert was excised from the gel and purified with the
QIAquick gel extraction kit (Qiagen).
Heteroduplex tracking assay (PfMSP1 HTA). The hetero-
duplex annealing reaction mixtures consisted of 5 L of PCR-
amplified block 2 of PfMSP1 from patient samples or 5 L of
gel-purified amplicons from the plasmid DNA controls, 1 L
of 10× annealing buffer (1 M NaCl, 100 mM Tris-HCl, pH 7.5,
20 mM EDTA), 0.1 M of C1F primer, and 1 L of 35S-
labeled probe in a total volume of 10 L. The C1F primers
were added to the annealing reaction to bind excess probe.8
The DNA duplexes were denatured at 95°C for 2 minutes
followed by annealing at 25°C for 5 minutes. Heteroduplexes
were mixed with 6× DNA loading buffer (Promega) and sepa-
rated by electrophoresis on a 6% polyacrylamide gel (acryla-
mide:bisacrylamide  37.5:1) in 1× Tris-borate-EDTA buffer
at 17 mA per gel for 4.5 hours. The gels were dried onto filter
paper (Whatman, Florham Park, NJ) and exposed to BioMax
MR x-ray film (Eastman Kodak, Rochester, NY) for approxi-
mately 18 hours at 25°C. Alternatively, for quantitative data,
the dried gels were exposed to a phorphorimager screen for
two days and the band intensities were quantitated according
to the manufacturer’s instructions (Molecular Dynamics,
Sunnyvale, CA).
Figure 1 outlines the potential probe-sample interactions
observed in HTA experiments; the probe sequence is in bold
type and the sample, or unknown sequence, is in regular type.
Single-stranded probes, as shown in Figure 1A, are unordered
and flexible and therefore migrate more slowly than probes
annealed to their complement (homoduplexes) (Figure 1B).
When the probe and sample are not complementary, one of
three structural distortions occurs after annealing: 1) clus-
tered basepair mismatches cause a bulge between the probe
and the sample (Figure 1C), 2) deletions in the sample se-
quence cause the probe to loop out (Figure 1D), or, 3) inser-
tions in the sample sequence are looped out (Figure 1E). Any
one of the latter three complexes, either alone or in combi-
nation, retards the migration of the probe-sample complexes
compared with the homoduplexes.13
HTA-based sequence diversity. The HTA results are the
minimum number of sequences counted by two independent
investigators blinded to the nested PCR results. Only major
HTA bands, which contain approximately 10% or greater of
the total signal in an individual lane, were considered true
HTA heteroduplexes. Bands with less than 10% of the total
signal, or bands common to all lanes (which could represent
either true minority sequence variants or PCR artifacts) were
not counted; exclusion of minor bands could potentially bias
this study towards an underreporting of sequence diversity.
Sequencing and alignment of DNA. The DNA was se-
quenced at the University of North Carolina-Chapel Hill Au-
tomated DNA Sequencing Facility on a 3100 Genetic Ana-
lyzer (Applied Biosystems, Foster City, CA) using the ABI
PRISM™ BigDye™ Terminator Cycle Sequencing Ready
Reaction Kit FS with AmpliTaq DNA Polymerase, (Applied
Biosystems). Sequencing was performed from both directions
using the C1F and C3R primers. The DNA sequences were
aligned with Clustal-X (http://www2.ebi.ac.uk/clustalw/) and
displayed using GeneDoc (http://www.psc.edu/biomed/
genedoc/).
Nested PCR for genotyping P. falciparum. Seventeen AF
samples were genotyped for MSP1, MSP2, and glutamate-
rich protein (GLURP) as reported by Pickard and others10
using the methodology reported by Kamwendo and others14
and Snounou and others.15 Briefly, PfMSP1 block 2, the cen-
tral polymorphic region of MSP2, and GLURP were PCR
FIGURE 1. Principle of the heteroduplex tracking assay. Single
stranded probes (bold) are radiolabeled and annealed to Plasmodium
falciparum merozoite surface protein 1 amplicons from patient iso-
lates as described in the Materials and Methods. Radiolabeled probes
migrate on the gel alone as in A, a single-stranded probe, or in com-
plexes with the complementary DNA, such as B, homoduplexes, C,
heteroduplexes with clustered base pair mismatches, D, heterodu-
plexes with sample deletion(s), and E, heteroduplexes with sample
insertion(s).
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amplified using primers specific for the three known MSP1
allelic families (K1, MAD20, and RO33), the known MSP2
families (IC and FC27) or GLURP. Amplicons from the sec-
ondary (nested) PCR were resolved by electrophoresis on an
agarose gel and size polymorphisms were noted. Nested
PCRs and the interpretation of their results were conducted
by an investigator (DDK) masked to the HTA results.10,15
RESULTS
Development of the PfMSP1 HTA. To generate molecular
probes that established different PfMSP1 sequence variants,
the PfMSP1 block 2 region of four samples (AF22, AF42,
AF63, and MHP1452) were PCR amplified and cloned into
pT7Blue vector. The PCR amplicons from these clones were
FIGURE 2. A, Basic structure of the Plasmodium falciparum merozoite surface protein 1 (PfMSP1) gene (adapted from Tanabe and others1).
Conserved, semiconserved, and variable blocks of the gene are shown as closed, hatched, and open blocks, respectively. Shown below the PfMSP1
schematic is a multiple sequence alignment of the PfMSP1 block 2 clones used for the PfMSP1 heteroduplex tracking assay. All sequences are
pairwise aligned with the AF63 clone; conserved nucleotides are shown as dots and deletions are shown as dashes. Underlined nucleotides
correspond to the primers C1F and C3R used to amplify block 2 by a polymerase chain reaction. B, Individual pairwise alignments of AF63 with
AF22, AF42, and MHP1452. Black shading represent conserved nucleotides, gray regions represent nucleotide mismatches, and dashes represent
nucleotide insertions or deletions.
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344, 317, 335, and 371 basepairs (AF22, AF42, AF63, and
MHP1452, respectively). Figure 2 shows the DNA sequence
alignment of these amplicons and their relationship to the
PfMSP1 gene. Sequence differences between these probes, as
determined by pairwise alignment to AF63, are as follows: AF22
has 1 insertion of 9 nucleotides and 75 basepair mismatches,
AF42 has 1 deletion of 18 nucleotides and 68 mismatches, and
MHP1452 has 1 insertion of 36 nucleotides and no base-pair
mismatches (Figure 2B). Comparison of the AF22, AF42,
AF63, and MHP1452 sequences to PfMSP1 block 2 subtypes
K1, MAD20 and RO33 suggests that AF63 and MHP1452 are
allelic subtype K1, AF22 is MAD20, and AF42 is subtype
RO33 (date not shown). However, these PfMSP1 family as-
signments should be interpreted with caution because the re-
petitive nature of PfMSP1 makes estimates of genetic varia-
tion between PfMSP1 alleles difficult to quantify.16,17
Verification of the PfMSP1 HTA. By mixing a radiola-
beled AF63 probe with equal amounts of AF22 (MAD20),
AF42 (RO33), or MHP1452 (K1) amplicons, we determined
the ability of the AF63 probe to bind to different PfMSP1
subtypes. The K1 (AF63) probe can distinguish between all
three PfMSP1 families, as is evident by the three bands with
unique mobilities (Figure 3, lanes 2–4). The band of the AF42
(RO33) and AF22 (MAD20) heteroduplexes are much
sharper compared with the MHP1452 (K1) heteroduplex; the
diffuse signal of the AF63-MHP1452 complex suggests that it
is an unstable, dynamic heteroduplex. Quantitation of the
area of the heteroduplex bands determined that the signal of
the diffuse MHP1452 complex is not equivalent to the signal
of the tighter AF22 or AF42 signals, lending further support
to the notion that the AF63 probe does not anneal tightly to
the MHP1452 sequence (date not shown).
To test the ability of the AF63 probe to detect sequences
similar to itself, we annealed the AF63 amplicon with AF63
probe. As seen in Figure 3, lane 7, this complex does not
comigrate with the probe homoduplex; instead, it comigrates
to a position similar to the AF22-AF63 heteroduplex, possibly
because the AF63 probe is longer than the amplicon. Diges-
tion of the AF63 probe with Nde I, which removes most of the
extra nucleotides, caused the AF63 probe/AF63 amplicon
complex to comigrate with the probe homoduplex (date not
shown). This observation suggests that the AF63 probe can
detect PfMSP1 sequence variants that are very similar to the
probe sequence. Furthermore, annealing the plasmid-derived
amplicons to a radiolabeled AF22 probe yielded HTA migra-
tion patterns similar to the AF63 probe (Figure 3, lanes 9–11).
These data support the notion that the HTA probes devel-
oped within this study are capable of binding to sequence
variants from all of the PfMSP1 allelic families.
Next, we investigated the ability of the HTA to probe a
mixture of PfMSP1 sequence variants, as would be found in
an isolate from a patient with a multiclonal infection. As ex-
pected, when AF22 and AF42 block-2 amplicons are mixed
and annealed to an AF63 probe, two heteroduplex bands are
observed (Figure 3, lane 5). Furthermore, a mixture of AF22,
AF42, and MHP1452 annealed to the AF63 probe yields
three heteroduplex bands (Figure 3, lane 6). These results
show that the HTA using a single probe can simultaneously
detect multiclonal and multifamily infections.
To determine if one HTA probe is more sensitive than the
others in the detection of PfMSP1 sequence variants, 17 AF
samples were annealed individually with all four probes. Fig-
ure 4 shows the HTA patterns of four representative patient
samples. Each of the probes yielded different patterns of ma-
jor bands, and in some cases the probes identified an unequal
number of sequence variants for each sample. However, these
differences were not due to assay reproducibility or biased
sequence sampling because all samples were PCR amplified
in duplicate, and in every case, the HTA pattern was identical
between replicates (date not shown). Although no single
probe always detected more sequence variants than the oth-
ers, the AF63 probe most consistently detected the largest
number of PfMSP1 sequence variants. Overall, depending on
the probe used, between five and seven unique PfMSP1 se-
quences were detected in the AF study population, which
reflects the low malaria transmission of this region.
Next, we compared the sensitivities of the PfMSP1 HTA to
the nested PCR in two ways in 17 clinical samples (Figure 5).
First, a comparison was made between the number of size
variants detected by the PfMSP1 nested PCR alone to the
number of sequence variants detected by a single HTA probe
(AF63). The HTA detected more sequence variants in 8
(47%) of 17 isolates, less sequence variants in 3 (18%) of 17
isolates, and an equal number in 6 (35%) of 17 isolates. Sec-
ond, a nested PCR of PfMSP1, MSP2, and GLURP was com-
pared with HTA using all four probes. Again, the HTA de-
tected more sequence variants in 8 (47%) of 17 isolates, less
sequence variants in 3 (18%) of 17 isolates, and an equal
number in 6 (35%) of 17 isolates. These results suggest that
the HTA is equivalent to or better than the nested PCR in
determining the number of P. falciparum sequence variants in
a patient isolate.
FIGURE 3. Autoradiogram of Plasmodium falciparum merozoite
surface protein 1 heteroduplex tracking assay analysis using the AF63
probe (lanes 1–7) and the AF22 probe (lanes 8–11). Probes were
annealed with equal amounts of polymerase chain reaction products
amplified from AF22, AF42, AF63, and MHP1452 plasmids.
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Application of the PfMSP1 HTA. Finally, the HTA was
evaluated for its ability to distinguish a recrudescent P. falci-
parum infection from a new infection. The PfMSP1 block 2
was amplified from seven matched GR admission and recur-
rent samples. The PCR products were annealed with probe
AF63 and the heteroduplex pattern of the parasite infection
at the time of admission (labeled A) was compared with that
of recurrent parasites (labeled R). As shown in Figure 6, the
HTA pattern of four recurrent samples matched or was con-
tained within the pattern of their paired admission samples
(GR1, GR4,GR10, and GR27). These infections could repre-
sent one of two outcomes: a recrudescence infection from a
patient who failed drug treatment, or a reinfection with para-
sites containing the same compliment of sequence variants as
the initial infection.18,19 The three samples that contained se-
quence variants novel to their readmission isolates (GR8,
GR12, and GR22) comprise patterns most likely associated
with reinfections. However, the novel bands in these samples
could also represent an outgrowth of a minor parasite popu-
lation that was originally undetected.
DISCUSSION
A critical variable in the evaluation of malaria treatment is
the ability to differentiate new parasite infections from recru-
descent infections. Efficacy studies of new and failing drugs
rely on any combination of World Health Organization20
clinical standards and molecular genotyping methods, such as
the nested PCR,21 RFLP,22 or SSCP23 for the classification of
P. falciparum drug sensitivity. Although these techniques are
frequently used, they are not without limitations. For ex-
ample, the nested PCR and RFLP rely on electrophoretic
migration of relatively small DNA fragments, which is
only sensitive to changes in the size of the fragments. How-
ever, fragments with a similar number of nucleotides but
with different sequences will migrate the same distance in
these methods, leading to genotype misclassification.24 Un-
like the nested PCR and RFLP, SSCP can detect single nucle-
otide differences, but it is technically demanding and is most
effective when fragment sizes are less than 150 basepairs.24
Finally, direct DNA sequencing can be used to detect se-
quence and size discrepant variants, but it is costly and unless
complemented with cloning, ineffective at determining the
number of sequence variants when multiple sequences are
present.5
In contrast to these techniques, the HTA method discussed
herein is simple and can detect clustered nucleotide mis-
matches as well as size polymorphisms. Although the extent
of mismatch clustering required for a mobility shift has not
been empirically defined, a 5% sequence divergence between
HIV variants is the reported threshold of detection.13 Fur-
thermore, studies on HIV have also shown that the HTA can
detect a unique viral population comprising just 3–5% of the
viral swarm.8,25 Another advantage of the HTA is that once a
FIGURE 4. Autoradiogram of Plasmodium falciparum merozoite surface protein 1 heteroduplex tracking assay analysis using probes developed
from the AF22, AF42, AF63, and the MHP1452 samples. The probes were annealed with polymerase chain reaction products amplified from four
patient isolates (AF18, AF38, AF43, and AF62). Sample number indicates the AF sample number and P indicates the probe alone lane. The
number of sequence variants enumerated per patient sample is listed under each lane.
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probe is developed, analysis of genotype diversity is relatively
rapid and large numbers of samples can be processed without
difficulty. One potentially negative aspect of this assay is the
use of radioactive nucleotides, which, although not evaluated
in this study, could be substituted with fluorescent or bio-
chemically modified nucleotides.
In general, when the degree of divergence between an-
nealed sequences exceeds 4.5%, the distance of heteroduplex
migration is proportional to the degree of heterogeneity be-
tween the sequences.13 However, the AF63/MHP1452 hetero-
duplex, which is a complex of two K1 family members, mi-
grates much more slowly than the AF63/AF22 heteroduplex,
which comprises sequences of the K1 and MAD20 families.
This unexpected migration is consistent with the observations
of Upchurch and others, who showed that heterogeneity near
the center of the heteroduplex influences migration more
than heterogeneity near the ends, and that unpaired bases
retard mobility more than mismatched bases.13 Indeed, pair-
wise alignment of AF63 with AF22 shows that AF 22 has a 9
basepair insertion 70 basepairs from the 5end of the com-
plex, as well as several nucleotide mismatches, while the
AF63/MHP1452 heteroduplex has no basepair mismatches,
but a large, 36-basepair insertion near the center of the het-
eroduplex (Figure 2B).
In a direct comparison by independent researchers masked
to the results of the other assay, the HTA documented a
greater amount of sequence diversity than the nested PCR.
Furthermore, the HTA only required a single PCR amplifi-
cation per sample, while the nested PCR requires three to six
PCRs per sample, depending on the number of genes assayed.
Even if the HTA and nested PCR gave identical results in
terms of sequence diversity, the reduction in the number of
PCRs per sample makes the HTA a more desirable method.
The DNA fingerprints of a parasite infection present at the
time of admission compared with that of reappearing para-
sites are widely used to distinguish recrudescence from rein-
fection.5 Since malaria infections are frequently composed of
multiple P. falciparum sequence variants at the time of ad-
mission,26,27 the HTA fingerprint will most likely contain
more than one heteroduplex. However, once treatment has
FIGURE 6. Heteroduplex tracking assay autoradiograms of the
AF63 probe annealed to seven paired primary and recurrent isolates
from the GR study. A indicates samples taken at admission and R
refers to samples taken from the same patient 7–42 days post-
treatment as described in the Materials and Methods.
FIGURE 5. Plasmodium falciparum multiplicity of infection as determined by nested a polymerase chain reaction (PCR) or a heteroduplex
tracking assay (HTA). The AF study numbers are listed below the groups of bars, and the number of sequence variants per isolate is listed by
method. Open bars represent the P. falciparum merozoite surface protein 1 (PfMSP1) nested PCR, thin diagonal lines represent the AF63 HTA,
gray boxes represent the PfMSP1, MSP2, and glutamate-rich protein (GLURP) nested PCRs, and thick diagonal lines represent HTA with all
four probes.
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begun, drug-sensitive clones are eliminated, leaving only the
drug-resistant clones.28 The appearance of new sequence
variants could either represent a reinfection or an expansion
of a minority sequence variant that was initially undetectable
(see GR samples 8, 12, and 22 in Figure 6). In future studies,
this problem can be addressed by collecting blood samples
from patients on two consecutive days.
In summary, we describe the use of a PCR followed by the
HTA to analyze block 2 of the MSP1 gene. The assay is
simple, has a high resolution, and is sensitive enough to detect
simultaneous, multifamily sequence variants in a patient iso-
late. These characteristics warrant the use of the PfMSP1
HTA in studies of anti-malarial drug efficacy.
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